Introduction
The global medical device industry is rapidly transforming with the integration of connected software, cloud platforms, mobile apps and AI-enabled technologies. While this innovation improves patient outcomes and healthcare efficiency, it also increases cybersecurity risks. For Indian medical device manufacturers targeting the European market, cybersecurity is no longer optional it is a regulatory requirement.
The European Union Medical Device Regulation (EU MDR) requires manufacturers to demonstrate that medical devices are secure throughout their lifecycle. Vulnerability Assessment and Penetration Testing (VAPT) has become a critical component of regulatory readiness and CE marking success.
Cyberintelsys supports medical device companies in India by delivering specialized EU MDR-aligned VAPT services that help meet cybersecurity expectations, strengthen product safety and accelerate regulatory approval.
EU MDR Cybersecurity Requirements
Medical devices sold in Europe must comply with Regulation (EU) 2017/745 (EU MDR), the primary regulatory framework governing device safety, performance and lifecycle monitoring.
EU MDR replaces earlier directives and introduces a lifecycle-based regulatory approach that significantly strengthens safety, documentation and post-market surveillance obligations.
Cybersecurity is embedded directly into the General Safety and Performance Requirements (GSPR).
Key requirements include:
Medical device software must be designed for secure and reliable performance.
Devices must prevent unauthorized access that could compromise safety.
Manufacturers must provide secure configuration and update information.
Security must be considered across the entire device lifecycle.
EU MDR treats cybersecurity as part of patient safety, requiring manufacturers to demonstrate continuous risk management, monitoring and vulnerability management.
For Indian manufacturers exporting to Europe, demonstrating cybersecurity through VAPT is essential to pass Notified Body assessments and obtain CE marking.
Why EU MDR VAPT Is Critical for Medical Device Manufacturers in India
1. Mandatory Evidence for CE Marking
Notified Bodies expect evidence of security testing as part of technical documentation and risk management. Without validated security testing, CE certification may be delayed or rejected.
2. Protection of Patient Safety
Cyberattacks on medical devices can disrupt care, leak sensitive health data, or manipulate device behavior creating direct risks to patients and hospitals.
3. Increased Scrutiny of Connected Devices
Software as a Medical Device (SaMD), mobile apps, cloud-connected devices and IoT healthcare systems face heightened regulatory scrutiny.
4. Lifecycle Security Requirements
EU MDR requires manufacturers to monitor vulnerabilities after product release, making ongoing testing essential.
5. Faster Market Entry into Europe
Strong cybersecurity documentation accelerates approval timelines and reduces costly redesigns during certification.
6. Competitive Advantage for Indian MedTech Firms
Indian manufacturers with EU-ready cybersecurity testing gain a major advantage when entering global healthcare markets.
Our Methodology – EU MDR Medical Device VAPT Approach
Cyberintelsys follows a structured VAPT methodology aligned with EU MDR lifecycle security expectations.
1. Regulatory Gap Assessment
Evaluation of existing cybersecurity practices against EU MDR expectations, including:
Secure software development lifecycle (SSDLC)
Risk management integration
Documentation readiness
Post-market monitoring capability
2. Threat Modeling and Risk Analysis
Identification of device-specific threats based on:
Device functionality and architecture
Connectivity and data flows
Cloud and mobile integrations
Third-party components and libraries
This aligns cybersecurity testing with ISO 14971 risk management practices.
3. Vulnerability Assessment
Comprehensive scanning and manual validation to identify:
Software vulnerabilities
Network and infrastructure weaknesses
Cloud and API risks
Embedded system vulnerabilities
Third-party component risks
4. Penetration Testing
Simulated real-world attacks targeting:
Device firmware and operating systems
Mobile and web applications
Wireless communication protocols
Authentication and access control
Data storage and transmission
5. Secure Configuration and Hardening Review
Assessment of:
Encryption implementation
Key management practices
Secure update mechanisms
Default configuration risks
6. Compliance Documentation Support
Creation of evidence required for:
Technical documentation
Risk management files
Security testing reports
Notified Body assessments
7. Retesting and Remediation Validation
Verification of fixes and validation of security improvements prior to submission.
Cyberintelsys EU MDR VAPT Services for Medical Devices
Cyberintelsys delivers end-to-end security testing services tailored for medical device manufacturers in India.
1. Medical Device Penetration Testing
Testing real-world attack scenarios against devices and software.
Includes:
Embedded device testing
IoT medical device testing
Firmware analysis
Wireless protocol testing (Bluetooth, Wi-Fi, BLE)
Hardware interface testing (USB, JTAG, UART)
2. Software as a Medical Device (SaMD) Security Testing
Security testing for standalone medical software and AI-driven platforms.
Includes:
Secure code review
API security testing
Authentication and authorization testing
Data privacy and encryption validation
AI/ML model security assessment
3. Mobile Medical App Security Testing
Testing healthcare apps interacting with devices and cloud platforms.
Includes:
Android and iOS security testing
Secure data storage validation
Reverse engineering testing
API and backend security testing
4. Cloud & Backend Security Testing
Assessment of healthcare cloud environments supporting devices.
Includes:
Cloud configuration reviews
Infrastructure penetration testing
Identity and access management testing
Container and microservices security testing
5. Medical Device Risk Management Support
Helping integrate cybersecurity into ISO 14971 processes.
Includes:
Threat modeling workshops
Risk documentation alignment
Security control mapping
Residual risk justification
6. EU MDR Documentation Support
Deliverables designed for regulatory submission:
VAPT reports aligned with MDR expectations
Security risk assessment reports
Remediation and mitigation guidance
Evidence for Notified Body audits
Why Choose Cyberintelsys
Cyberintelsys is a CREST-accredited cybersecurity company for Vulnerability Assessment (VA) and Penetration Testing (PT), delivering industry-recognized security testing services for organizations across multiple sectors.
Medical device manufacturers in India choose Cyberintelsys because:
1. Deep MedTech Security Expertise
Experience in testing connected healthcare devices, SaMD and IoT ecosystems.
2. EU MDR-Aligned Testing Approach
Testing aligned with EU MDR lifecycle security expectations and Notified Body requirements.
3. End-to-End Compliance Support
From gap assessment to remediation validation and documentation support.
4. Faster Regulatory Readiness
Security testing integrated into development cycles to avoid costly redesigns.
5. Global Market Enablement
Helping Indian MedTech companies expand into Europe with confidence.
Strengthen EU MDR Compliance with Cyberintelsys
For Indian medical device manufacturers, cybersecurity is now a fundamental requirement for entering the European market. EU MDR demands strong security testing, ongoing monitoring and documented evidence of risk management.
Cyberintelsys helps organizations build secure medical devices, meet EU MDR expectations and accelerate CE marking readiness.
Contact Cyberintelsys today to strengthen your medical device cybersecurity and achieve EU MDR compliance with confidence.
